Aspire Biopharma Hldgs Inc.
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 30 institutions reported holding Aspire Biopharma Hldgs Inc. in their 13F filings, up 5 from Q3 2025. 6 opened new positions and 2 sold out. The largest holders were UBS Group AG ($332K), Crewe Advisors LLC ($107K) and Jane Street Group, LLC ($91K). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Aspire Biopharma Hldgs Inc.
- CUSIP
- 738920107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $39K |
| Exits | 2 | $3K |
All 13F filers, Q3 2025 → Q4 2025: 3,917,311 shares bought and 279,575 shares sold, net +3,637,736 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| UBS Group AG | 0.00% | Add +32727.0% | 2,514,873 | $332K |
| Crewe Advisors LLC | 0.01% | No change | 813,427 | $107K |
| Jane Street Group, LLC | 0.00% | Add +2252.1% | 688,143 | $91K |
| Vanguard Group Inc. | 0.00% | No change | 428,552 | $57K |
| Optivise Advisory Services LLC | 0.03% | Add +35.6% | 357,340 | $47K |
| XTX Topco Ltd | 0.00% | Add +853.2% | 265,471 | $35K |
| Geode Capital Management, LLC | 0.00% | Reduce -1.0% | 247,555 | $33K |
| Procyon Advisors, LLC | 0.00% | Reduce -50.8% | 232,661 | $31K |
| Antara Capital LP | 100.00% | No change | 202,897 | $27K |
| Resolute Advisors LLC | 0.01% | Add +88.2% | 155,826 | $21K |
| Three Seasons Wealth, LLC | 0.00% | Add +66.7% | 125,000 | $16K |
| Virtu Financial LLC | 0.00% | New | 108,791 | $14K |
| VR Advisory Services Ltd | 0.00% | No change | 97,391 | $13K |
| Verition Fund Management LLC | 0.00% | New | 97,391 | $13K |
| EP Wealth Advisors, LLC | 0.00% | — | 62,685 | $8K |
| P Schoenfeld Asset Management LP | 0.00% | No change | 58,563 | $8K |
| Avion Wealth | 0.00% | No change | 54,113 | $7K |
| Scientech Research LLC | 0.00% | New | 51,602 | $7K |
| Periscope Capital Inc. | 0.00% | No change | 50,000 | $7K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 49,129 | $6K |
| Valley Wealth Managers, Inc. | 0.00% | No change | 40,000 | $5K |
| Platform Technology Partners | 0.00% | No change | 37,611 | $5K |
| Crossingbridge Advisors, LLC | 0.00% | No change | 24,348 | $3K |
| StoneX Group Inc. | 0.00% | New | 14,675 | $2K |
| Point72 Asset Management | 0.00% | New | 14,244 | $2K |
| Allred Capital Management, LLC | 0.00% | No change | 11,185 | $1K |
| Fisher Asset Management | 0.00% | New | 10,000 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -69.1% | 9,609 | $1K |
| Bank of America Corp. | 0.00% | Add +11.5% | 282 | $37 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $13 |
"% of holder's portfolio" is ASPIRE BIOPHARMA HLDGS INC's weight in each manager's 13F, not the share of Aspire Biopharma Hldgs Inc. the manager owns.